🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523412-36-00
Completed Phase I

A clinical study of MK-1045 in people with lupus or rheumatoid arthritis (MK-1045-004)

2025-523412-36-00 · tracked via the Priya Life Science EU tracker
Sponsor
Merck Sharp & Dohme LLC
Sponsor type
Pharmaceutical company
Therapeutic area
Immune System Diseases
Decision date
02/02/2026
Enrollment target
11
Sites
Italy, Belgium, Romania

Condition studied

Systemic lupus erythematosus, Rheumatoid arthritis

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523412-36-00 on CTIS ↗ ← All trials in the EU